Caspase-1α is down-regulated in human ovarian cancer cells and the overexpression of caspase-1α induces apoptosis

Cancer Research

Volumn 65, Issue 19, 2005, Pages 8591-8596

  Feng, Qiang ^a   Li, Peixiang ^a   Salamanca, Clara ^a   Huntsman, David ^a   Leung, Peter C K ^a   Auersperg, Nelly ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 1ALPHA; CYTOKINE; DEOXYURIDINE TRIPHOSPHATE DERIVATIVE; INTERLEUKIN 1BETA CONVERTING ENZYME; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; CASP3 PROTEIN, HUMAN; CASP9 PROTEIN, HUMAN; CASPASE; CASPASE 3; CASPASE 9; CISPLATIN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CASP1 GENE; CONTROLLED STUDY; GENE; GENE CONTROL; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; NERVE CELL; OVARY CANCER; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEADY STATE; WESTERN BLOTTING; BIOSYNTHESIS; DOWN REGULATION; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; FEMALE; FLUORESCENCE MICROSCOPY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; METABOLISM; OVARY TUMOR; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASE 1; CASPASE 3; CASPASE 9; CASPASES; CELL LINE, TUMOR; CISPLATIN; DOWN-REGULATION; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICROSCOPY, FLUORESCENCE; OVARIAN NEOPLASMS; TRANSFECTION;

EID: 25444495215     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-0239     Document Type: Article

References (20)

1. Wolf BB, Schuler M, Li W, et al. Defective cytochrome c-dependent caspase activation in ovarian cancer cell lines due to diminished or absent apoptotic protease activating factor-1 activity. J Biol Chem 2001;276:34244-51.
2. Abedini MR, Qiu Q, Yan X, Tsang BK. Possible role of FLICE-like inhibitory protein (FLIP) in chemoresistant ovarian cancer cells in vitro. Oncogene 2004;23:6997-7004.
3. Schimmer AD. Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice. Cancer Res 2004;64:7183-90.
4. Banelli B, Casciano I, Croce M, et al. Expression and methylation of CASP8 in neuroblastoma: identification of a promoter region. Nat Med 2002;8:1333-5.
5. Zhang WH, Wang X, Narayanan M, et al. Fundamental role of the Rip2/caspase-1 pathway in hypoxia and ischemia-induced neuronal cell death. Proc Natl Acad Sci U S A 2003;100:16012-7.
6. Sanchez Mejia RO, Friedlander RM. Caspases in Huntington's disease. Neuroscientist 2001;7:480-9.
7. Feng Q, Li P, Leung PC, Auersperg N. Caspase-1ζ, a new splice variant of the caspase-1 gene. Genomics 2004;84:587-91.
8. Tschopp J, Martinon F, Burns K. NALPs: a novel protein family involved in inflammation. Nat Rev Mol Cell Biol 2003;4:95-104.
9. Jarry A, Valletta G, Cassagnau E, et al. Interleukin 1 and interleukin 1β converting enzyme (caspase 1) expression in the human colonic epithelial barrier. Caspase 1 downregulation in colon cancer. Gut 1999;45:246-51.
10. Winter RN, Kramer A, Borkowski A, Kyprianou N. Loss of caspase-1 and caspase-3 protein expression in human prostate cancer. Cancer Res 2001;61:1227-32.
11. Davis M, Hitchcock A, Foulkes WD, Campbell IG. Refinement of two chromosome 11q regions of loss of heterozygosity in ovarian cancer. Cancer Res 1996;56:741-4.
12. Foulkes WD, Campbell IG, Stamp GW, Trowsdale J. Loss of heterozygosity and amplification on chromosome 11q in human ovarian cancer. Br J Cancer 1993;67:268-73.
13. Auersperg N, Wong AS, Choi KC, Kang SK, Leung PC. Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr Rev 2001;22:255-88.
14. Maines-Bandiera SL, Kruk PA, Auersperg N. Simian virus 40-transformed human ovarian surface epithelial cells escape normal growth controls but retain morphogenetic responses to extracellular matrix. Am J Obstet Gynecol 1992;167:729-35.
15. Yao KS, Godwin AK, Johnson SW, Ozols RF, O'Dwyer PJ, Hamilton TC. Evidence for altered regulation of γ-glutamylcysteine synthetase gene expression among cisplatin-sensitive and cisplatin-resistant human ovarian cancer cell lines. Cancer Res 1995;55:4367-74.
16. Funkhauser C, Friedlander RM, Gagliardini V. Prevention of nuclear localization of activated caspases correlates with inhibition of apoptosis. Apoptosis 2000;5:117-32.
17. Humke EW, Shriver SK, Starovasnik MA, Fairbrother WJ, Dixit VM. ICEBERG: a novel inhibitor of interleukin-1β generation. Cell 2000;103:99-111.
18. Ziltener HJ, Maines-Bandiera S, Schrader JW, Auersperg N. Secretion of bioactive interleukin-1, interleukin-6, and colony-stimulating factors by human ovarian surface epithelium. Biol Reprod 1993;49:635-41.
19. Wang ZY, Gaggero A, Rubartelli A, et al. Expression of interleukin-18 in human ovarian carcinoma and normal ovarian epithelium: evidence for defective processing in tumor cells. Int J Cancer 2002;98:873-8.
20. King AR, Francis SE, Bridgeman CJ, Bird H, Whyte MK, Crossman DC. A role for caspase-1 in serum withdrawal-induced apoptosis of endothelial cells. Lab Invest 2003;83:1497-508.